These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7312844)

  • 41. [Phosphorus metabolism in combined therapy of tuberculosis in children].
    Maliuk VI; Rushchak VA; Bel'tman RP
    Probl Tuberk; 1979 Jul; (7):37-41. PubMed ID: 315553
    [No Abstract]   [Full Text] [Related]  

  • 42. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
    Moulding T
    Int J Tuberc Lung Dis; 2000 May; 4(5):485-6. PubMed ID: 10815744
    [No Abstract]   [Full Text] [Related]  

  • 43. [The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
    Borisova MI; Stakhanov VA; Sharkova TI; Ivashchenko NA
    Probl Tuberk Bolezn Legk; 2003; (7):34-7. PubMed ID: 12939876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Supervision in the chemotherapy of tuberculosis].
    Bignall JR
    Plucne Bolesti Tuberk; 1970; 22(4):310-4. PubMed ID: 5208398
    [No Abstract]   [Full Text] [Related]  

  • 45. [The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
    Iwanaga T; Yokota K; Kishikawa R; Ikeda T; Tsurutani H; Hirose T; Nishima S
    Kekkaku; 1997 Jan; 72(1):9-13. PubMed ID: 9038010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1982 Feb; 24(603):17-9. PubMed ID: 7057741
    [No Abstract]   [Full Text] [Related]  

  • 48. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 49. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy].
    Ubaĭdullaev AM; Belotserkovskiĭ VG
    Probl Tuberk; 1999; (6):14-6. PubMed ID: 10715948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report.
    Swaminathan S; Raghavan A; Duraipandian M; Kripasankar AS; Ramachandran P
    Int J Tuberc Lung Dis; 2005 Jun; 9(6):693-6. PubMed ID: 15971400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chemotherapy effectiveness in destructive pulmonary tuberculosis in the middle-aged and elderly using different methods of administering the preparations].
    Abrarov BA; Tursunov FI; Leĭbzon IuN; Slobodskoĭ SA; Arifov SA
    Probl Tuberk; 1982 Mar; (3):34-7. PubMed ID: 7088920
    [No Abstract]   [Full Text] [Related]  

  • 52. [Improved technology of chemotherapy of pulmonary tuberculosis complicated by other diseases].
    Gavril'ev SS; Nikolaev VP; Vinokurova MK; Petukhova NIu; Gavril'eva LP; Malogulova ISh
    Probl Tuberk; 2001; (2):8-11. PubMed ID: 11490482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Laboratory monitoring by urine analysis of pulmonary tuberculosis patient compliance in taking 2d series preparations and isoniazid derivatives].
    Radkevich RA; Utkin VV; Guseva TM
    Lab Delo; 1978; (2):84-6. PubMed ID: 76009
    [No Abstract]   [Full Text] [Related]  

  • 56. Short-course chemotherapy for tuberculosis.
    Ng HK
    Xianggang Hu Li Za Zhi; 1984 Nov; (37):26-31. PubMed ID: 6241591
    [No Abstract]   [Full Text] [Related]  

  • 57. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 58. [Inactivation of the HINA preparations and certain indicators of the detoxicating function of the liver in patients with pulmonary tuberculosis].
    Fitsaĭ AV
    Probl Tuberk; 1973; 51(6):83-4. PubMed ID: 4764137
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [6-month chemotherapy of newly detected tuberculosis].
    Niemirowska H; Krychniak W; Westfal I
    Pneumonol Pol; 1987 Jun; 55(6):246-50. PubMed ID: 3684726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.